Catalyst
Slingshot members are tracking this event:
The First Phase 3 trial for Plecanatide in IBS-C read out
Do you think this event is important to the companies below? How will it affect their stock price?
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 22, 2016
Occurred Source:
http://www.businesswire.com/news/home/20160522005035/en/Synergy-Pharmaceuticals-Presents-Plecanatide-Phase-3-Data
Related Projects
- Assessing the Phase III data in CIC for Plecanatide vs. Linzess and how different CIC vs. IBS-C data is for these drugs SGYP, AGN, IRWD Executed On: Jun 29, 2015 at 09:00 PM EDT
Related Keywords
Plecanatide, Phase 3, Ibs-c
